Worldwide Orphan Drugs Industry Reflecting a Compound Annual Growth Rate of 11.56% by 2022 – North America Region Accounts the Largest Market Share
The Orphan Drugs Market is developing exponentially owing to the growing investment in research and development and unmet needs for rare diseases are the key factor driving the orphan drugs Market.
View full press release